Additionally, there is consideration of the use of mesenchymal stem cells (MSCs) for supplying bioactive factors, such as brain-derived neurotrophic factors (BDNF), in treating neurologic disorders, such as HD [14,15,16]. The gene discussed is BDNF; the disease is nervous system disorder.